Certolizumab Pegol Efficacy in Patients with Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status

被引：0
|
作者：
Deodhar, Atul [1 ]
Gensler, Lianne [2 ]
Hall, Stephen [3 ,4 ]
Robinson, Philip [5 ]
Hoepken, Bengt [6 ]
Bauer, Lars [6 ]
Kumke, Thomas [6 ]
Maksymowych, Walter [7 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Monash Univ, Cabrini Med Ctr, Malvern, Vic, Australia
[4] Emeritus Res, Malvern, Vic, Australia
[5] Univ Queensland, Herston, Qld, Australia
[6] UCB Pharma, Monheim, Germany
[7] Univ Alberta, Edmonton, AB, Canada
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1358
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd Study
    Robinson, Philip C.
    Maksymowych, Walter P.
    Gensler, Lianne S.
    Hall, Stephen
    Rudwaleit, Martin
    Hoepken, Bengt
    Bauer, Lars
    Kumke, Thomas
    Kim, Mindy
    de Peyrecave, Natasha
    Deodhar, Atul
    [J]. ACR OPEN RHEUMATOLOGY, 2022, 4 (09) : 794 - 801
  • [2] LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS
    Robinson, P.
    Maksymowych, W. P.
    Gensler, L. S.
    Rudwaleit, M.
    Hoepken, B.
    Bauer, L.
    Kumke, T.
    Kim, M.
    Deodhar, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 774 - 775
  • [3] LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS
    Zochling, Jane
    Robinson, Philip C.
    Maksymowych, Walter P.
    Gensler, Lianne S.
    Rudwaleit, Martin
    Hoepken, Bengt
    Bauer, Lars
    Kumke, Thomas
    Kim, Mindy
    Deodhar, Atul
    [J]. INTERNAL MEDICINE JOURNAL, 2023, 53 : 25 - 25
  • [4] Long-Term Clinical Outcomes of Certolizumab Pegol Treatment in Patients with Active Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status
    Robinson, Philip C.
    Maksymowych, Walter P.
    Gensler, Lianne
    Rudwaleit, Martin
    Hoepken, Bengt
    Bauer, Lars
    Kumke, Thomas
    Kim, Mindy
    Deodhar, Atul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 808 - 810
  • [5] Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status
    Rudwaleit, Martin
    Deodhar, Atul
    Bauer, Lars
    Gensler, Lianne
    Hoepken, Bengt
    Kumke, Thomas
    Auteri, Simone Emanuele
    Kim, Mindy
    Maksymowych, Walter
    [J]. RMD OPEN, 2024, 10 (02):
  • [6] Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
    Spadaro, A.
    Scarno, A.
    Carboni, A.
    Perrotta, F. M.
    Catalano, C.
    Lubrano, E.
    Valesini, G.
    [J]. REUMATISMO, 2013, 65 (03) : 134 - 137
  • [7] SUSTAINED EFFICACY OF ADALIMUMAB IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS WITH POSITIVE MRI OF THE SACROILIAC JOINTS OR SPINE OR ELEVATED C-REACTIVE PROTEIN AT BASELINE
    Sieper, Joachim
    van der Heijde, Desiree
    Dougados, Maxime
    Van den Bosch, Filip
    Goupille, Philippe
    Rathmann, Suchitrita S.
    Pangan, Aileen L.
    [J]. RHEUMATOLOGY, 2013, 52 : 52 - 53
  • [8] Safety and Efficacy of Certolizumab Pegol over 204 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    Deodhar, Atul A.
    Dougados, Maxime
    Landewe, Robert
    Sieper, Joachim
    Maksymowych, Walter
    Rudwaleit, Martin
    van Den Bosch, Filip
    Braun, Juergen
    Mease, Philip J.
    Kivitz, Alan
    Walsh, Jessica
    Davies, Owen
    Hoepken, Bengt
    Peterson, Luke
    van der Heijde, Desiree
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] Certolizumab Pegol Effectiveness in Radiographic and Non-Radiographic Axial Spondyloarthritis. a Natiowide Study
    Gonzalez, Carlos M.
    Exposito, Rosa
    Garcia-Portales, Rosa
    Urruticoechea-Arana, Ana
    Ramon Lamua, Jose
    del Pilar Navarro, Maria
    Rey Rey, Jose Santos
    Fernandez, Manuel
    Morcillo, Mercedes
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] Response to Certolizumab Pegol in Patients with Non-Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Cut-Offs: Post-Hoc Analysis from a Phase 3 Multicenter Study
    Robinson, Philip
    Hall, Stephen
    Hoepken, Bengt
    Bauer, Lars
    Demas, Eleni
    Kim, Mindy
    Deodhar, Atul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1899 - 1901
12345